Durable response after the discontinuation of pembrolizumab treatment due to an adverse event in a patient with advanced endometrial cancer: A case report

por Umihira, Shuntaro, Koyanagi, Takahiro, Tamura, Kohei, Takahashi, Yoshifumi, Yoshiba, Takahiro, Takahashi, Suzuyo, Taneichi, Akiyo, Saga, Yasushi, Takei, Yuji, Fujiwara, Hiroyuki
Publicado 2022

Knockout of vasohibin‐2 reduces tubulin carboxypeptidase activity and increases paclitaxel sensitivity in ovarian cancer

por Koyanagi, Takahiro, Saga, Yasushi, Takahashi, Yoshifumi, Tamura, Kohei, Yoshiba, Takahiro, Takahashi, Suzuyo, Taneichi, Akiyo, Takei, Yuji, Urabe, Masashi, Mizukami, Hiroaki, Fujiwara, Hiroyuki
Publicado 2021

Downregulation of indoleamine-2,3-dioxygenase in cervical cancer cells suppresses tumor growth by promoting natural killer cell accumulation

por SATO, NAOTO, SAGA, YASUSHI, MIZUKAMI, HIROAKI, WANG, DONGDONG, TAKAHASHI, SUZUYO, NONAKA, HIROAKI, FUJIWARA, HIROYUKI, TAKEI, YUJI, MACHIDA, SHIZUO, TAKIKAWA, OSAMU, OZAWA, KEIYA, SUZUKI, MITSUAKI
Publicado 2012

Effect of providing risk information on undergoing cervical cancer screening: a randomized controlled trial

por Fujiwara, Hiroyuki, Shimoda, Akihiro, Ishikawa, Yoshiki, Taneichi, Akiyo, Ohashi, Mai, Takahashi, Yoshifumi, Koyanagi, Takahiro, Morisawa, Hiroyuki, Takahashi, Suzuyo, Sato, Naoto, Machida, Shizuo, Takei, Yuji, Saga, Yasushi, Suzuki, Mitsuaki
Publicado 2015